+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia

The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia

American Journal of Psychiatry 166(9): 1055-1062

Schizophrenia is treated with medications that raise serum anticholinergic activity and are known to adversely affect cognition. The authors examined the relationship between serum anticholinergic activity and baseline cognitive performance and response to computerized cognitive training in outpatients with schizophrenia. Fifty-five patients were randomly assigned to either computerized cognitive training or a computer games control condition. A neurocognitive battery based on the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) initiative was performed at baseline and after the intervention. Serum anticholinergic activity, measured at study entry by radioreceptor assay, was available for 49 patients. Serum anticholinergic activity showed a significant negative correlation with baseline performance in verbal working memory and verbal learning and memory, accounting for 7% of the variance in these measures, independent of age, IQ, or symptom severity. Patients in the cognitive training condition (N=25) showed a significant gain in global cognition compared to those in the control condition, but this improvement was negatively correlated with anticholinergic burden. Serum anticholinergic activity uniquely accounted for 20% of the variance in global cognition change, independent of age, IQ, or symptom severity. Serum anticholinergic activity in schizophrenia patients shows a significant association with impaired performance in MATRICS-based measures of verbal working memory and verbal learning and memory and is significantly associated with a lowered response to an intensive course of computerized cognitive training. These findings underscore the cognitive cost of medications that carry a high anticholinergic burden. The findings also have implications for the design and evaluation of cognitive treatments for schizophrenia.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 056266319

Download citation: RISBibTeXText

PMID: 19570929

DOI: 10.1176/appi.ajp.2009.09010017

Related references

Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study. Drugs and Aging 30(2): 103-112, 2013

Association of Anticholinergic Burden with Cognitive and Functional Status in a Cohort of Hospitalized Elderly Comparison of the Anticholinergic Cognitive Burden Scale and Anticholinergic Risk Scale. Drugs & Aging 30(2): 103-112, 2013

Verbal learning deficits associated with increased anticholinergic burden are attenuated with targeted cognitive training in treatment refractory schizophrenia patients. Schizophrenia Research 208: 384-389, 2019

Anticholinergic medications in patients admitted with cognitive impairment or falls (AMiCI). The impact of hospital admission on anticholinergic cognitive medication burden. Results of a multicentre observational study. Journal of Clinical Pharmacy and Therapeutics 43(5): 682-694, 2018

The Impact of Medication Anticholinergic Burden on Cognitive Performance in People With Schizophrenia. Journal of Clinical Psychopharmacology 37(6): 651-656, 2017

The influence of combined cognitive plus social-cognitive training on amygdala response during face emotion recognition in schizophrenia. Psychiatry Research 213(2): 99, 2013

Pnd114 - Impact Of A Pharmacist-Led Community Interventional Program To Prevent Cognitive Deterioration In Community-Dwelling Hong Kong Elders With High Anticholinergic Cognitive Burden. Value in Health 21: S347-S348, 2018

The interaction between medical burden and anticholinergic cognitive burden on neuropsychological function in a geriatric primary care sample. Archives of Clinical Neuropsychology 30(2): 105-113, 2015

Modafinil combined with cognitive training: pharmacological augmentation of cognitive training in schizophrenia. European Neuropsychopharmacology 25(8): 1178-1189, 2015

Preliminary evaluation of cognitive adaptation training to compensate for cognitive deficits in schizophrenia. Psychiatric Services 47(4): 415-417, 1996

Improved cognitive function in schizophrenia after one year of cognitive training and vocational services. Schizophrenia Research 96(1-3): 156-161, 2007

Divergence of subjective and performance-based cognitive gains following cognitive training in schizophrenia. Schizophrenia Research 210: 215-220, 2019

Cognitive remediation and social cognitive training for violence in schizophrenia: a systematic review. Psychiatry Research 251: 266-274, 2017

Neural activity during emotion recognition after combined cognitive plus social cognitive training in schizophrenia. Schizophrenia Research 139(1-3): 53-59, 2012

The effectiveness of computerized cognitive rehabilitation training program in improving cognitive abilities of schizophrenia clients. Iranian Journal of Psychiatry 9(4): 209-215, 2015